LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,574,797 | -14.3% | 159,793 | +3.2% | 0.03% | -11.1% |
| Q2 2023 | $11,168,723 | -0.6% | 154,906 | +1.4% | 0.04% | -7.7% |
| Q1 2023 | $11,236,584 | +19.2% | 152,754 | +8.2% | 0.04% | +8.3% |
| Q4 2022 | $9,427,350 | -73.8% | 141,128 | -66.2% | 0.04% | -74.6% |
| Q3 2022 | $35,914,000 | +1.6% | 417,075 | +5.3% | 0.14% | +8.4% |
| Q2 2022 | $35,335,000 | -65.6% | 396,044 | -56.7% | 0.13% | -57.3% |
| Q1 2022 | $102,827,000 | -52.5% | 914,099 | -34.7% | 0.31% | -47.4% |
| Q4 2021 | $216,297,000 | +12.8% | 1,400,341 | +1.8% | 0.58% | +7.9% |
| Q3 2021 | $191,696,000 | +17.2% | 1,375,941 | +10.4% | 0.54% | +5.5% |
| Q2 2021 | $163,522,000 | -16.9% | 1,246,452 | -3.5% | 0.51% | -19.5% |
| Q1 2021 | $196,852,000 | -3.0% | 1,291,254 | -36.7% | 0.64% | -5.8% |
| Q4 2020 | $202,982,000 | +12.4% | 2,041,045 | +7.7% | 0.68% | -4.0% |
| Q3 2020 | $180,667,000 | +8.7% | 1,895,374 | +27.5% | 0.70% | +4.0% |
| Q2 2020 | $166,265,000 | +50.4% | 1,486,504 | -2.2% | 0.68% | +25.8% |
| Q1 2020 | $110,556,000 | -25.2% | 1,520,296 | +7.3% | 0.54% | -8.7% |
| Q4 2019 | $147,763,000 | +11.1% | 1,416,850 | +6.0% | 0.59% | +3.5% |
| Q3 2019 | $133,000,000 | +29.8% | 1,336,143 | +48.9% | 0.57% | +32.3% |
| Q2 2019 | $102,435,000 | -8.2% | 897,370 | +1.1% | 0.43% | -8.5% |
| Q1 2019 | $111,585,000 | -15.9% | 887,642 | -9.2% | 0.47% | -28.7% |
| Q4 2018 | $132,617,000 | -53.1% | 977,284 | -5.1% | 0.66% | -32.7% |
| Q3 2018 | $282,773,000 | +20.0% | 1,030,175 | -9.4% | 0.98% | +11.8% |
| Q2 2018 | $235,555,000 | +38.6% | 1,137,011 | +10.5% | 0.88% | +35.0% |
| Q1 2018 | $169,968,000 | +0.1% | 1,029,111 | -17.0% | 0.65% | -1.7% |
| Q4 2017 | $169,803,000 | +8.7% | 1,240,071 | +8.1% | 0.66% | +18.1% |
| Q3 2017 | $156,215,000 | -27.4% | 1,147,376 | -35.3% | 0.56% | -28.6% |
| Q2 2017 | $215,295,000 | +17.7% | 1,773,434 | +2.6% | 0.78% | +13.3% |
| Q1 2017 | $182,910,000 | +48.2% | 1,728,178 | +42.3% | 0.69% | +40.2% |
| Q4 2016 | $123,420,000 | +23.0% | 1,214,647 | +23.6% | 0.49% | +29.7% |
| Q3 2016 | $100,316,000 | -33.0% | 982,908 | -21.7% | 0.38% | -35.8% |
| Q2 2016 | $149,717,000 | +13.7% | 1,255,277 | +2.1% | 0.59% | +13.4% |
| Q1 2016 | $131,662,000 | +6.5% | 1,229,452 | +7.8% | 0.52% | +4.2% |
| Q4 2015 | $123,654,000 | +6.7% | 1,140,511 | -15.7% | 0.50% | +112.3% |
| Q3 2015 | $115,849,000 | – | 1,352,586 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |